Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Accendra Health (ACH) Common Equity (2016 - 2025)

Historic Common Equity for Accendra Health (ACH) over the last 17 years, with Q3 2025 value amounting to -$429.5 million.

  • Accendra Health's Common Equity fell 14910.94% to -$429.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$429.5 million, marking a year-over-year decrease of 14910.94%. This contributed to the annual value of $586.4 million for FY2024, which is 3655.21% down from last year.
  • Per Accendra Health's latest filing, its Common Equity stood at -$429.5 million for Q3 2025, which was down 14910.94% from -$281.0 million recorded in Q2 2025.
  • In the past 5 years, Accendra Health's Common Equity ranged from a high of $966.8 million in Q3 2022 and a low of -$429.5 million during Q3 2025
  • Its 5-year average for Common Equity is $736.2 million, with a median of $887.0 million in 2021.
  • In the last 5 years, Accendra Health's Common Equity soared by 11460.03% in 2021 and then tumbled by 14910.94% in 2025.
  • Over the past 5 years, Accendra Health's Common Equity (Quarter) stood at $938.5 million in 2021, then grew by 0.76% to $945.6 million in 2022, then fell by 2.27% to $924.2 million in 2023, then plummeted by 36.55% to $586.4 million in 2024, then crashed by 173.25% to -$429.5 million in 2025.
  • Its Common Equity stands at -$429.5 million for Q3 2025, versus -$281.0 million for Q2 2025 and $571.0 million for Q1 2025.